LAMP
Truveris, Inc.
Application Filed: 2014-08-05
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86357775 |
| Registration Number | 4707895 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Kristen McCallion |
| Attorney Docket Number | 42817-000700 |
| Law Office Assigned | N10 |
| Employee Name | TANNER, MICHAEL R |
Timeline
| 2014-03-21 | Date of First Use |
| 2014-08-05 | Application Filed |
| 2015-01-06 | Published for Opposition |
| 2015-03-24 | Location: PUBLICATION AND ISSUE SECTION |
| 2015-03-24 | Status: Live/Registered |
| 2015-03-24 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  TRUVERIS, INC. |
| Address | 2 Park Avenue Suite 1500 New York DE 10016 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Platform as a service (PAAS) featuring computer software platforms for use in tracking and monitoring pharmaceutical drug sales and dispensations, for use in tracking, analyzing and determining pharmaceutical drug market share, for use in tracking, analyzing and determining pharmaceutical drug co-pay distribution, for use in tracking, monitoring, analyzing and determining patient-adherence or patient-abandonment to pharmaceutical drug administration, for use in tracking, monitoring and analyzing pharmaceutical drug pricing, for use in tracking and monitoring pharmaceutical drug loss-of-exclusivity readiness, for use in evaluating, comparing and analyzing the different market performance attributes of similar pharmaceutical drugs, and for use in monitoring, tracking and reporting on the market performance of various pharmaceutical drugs throughout their respective lifecycles; Software as a service (SAAS) services featuring software for use in tracking and monitoring pharmaceutical drug sales and dispensations, for use in tracking, analyzing and determining pharmaceutical drug market share, for use in tracking, analyzing and determining pharmaceutical drug co-pay distribution, for use in tracking, monitoring, analyzing and determining patient-adherence or patient-abandonment to pharmaceutical drug administration, for use in tracking, monitoring and analyzing pharmaceutical drug pricing, for use in tracking and monitoring pharmaceutical drug loss-of-exclusivity readiness, for use in evaluating, comparing and analyzing the different market performance attributes of similar pharmaceutical drugs, and for use in monitoring, tracking and reporting on the market performance of various pharmaceutical drugs throughout their respective |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2014-08-08 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-08-14 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2014-09-16 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | 2014-09-23 | 4 CPEA R:Renewal |
| COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | 2014-09-23 | 5 EPEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2014-09-23 | 6 GEAP F:First Action |
| NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | 2014-09-23 | 7 GEAN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2014-10-27 | 8 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2014-10-29 | 9 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-11-04 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-11-04 | 11 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2014-11-22 | 12 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2014-12-03 | 13 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2014-12-17 | 14 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2015-01-06 | 15 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-01-06 | 16 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2015-03-24 | 17 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2015-12-29 | 18 TCCA I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2016-03-02 | 19 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2016-03-02 | 20 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2016-03-03 | 21 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2016-03-03 | 22 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-02-04 | 23 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-02-04 | 24 ARAA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2020-03-24 | 25 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2021-03-24 | 26 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2021-07-27 | 27 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2021-07-30 | 28 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2021-07-30 | 29 NA85 E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2024-02-01 | 30 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2024-02-01 | 31 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-02-01 | 32 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2024-03-24 | 33 REM2 E:E-Mail |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 